Can Europe afford the next generation of medicines?
There is a wave of cell and gene therapies in the pipeline, but EU countries will have to deal with hefty price tags.
Source: politico.eu
Stay updated with breaking news from Anticancer Fund. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
There is a wave of cell and gene therapies in the pipeline, but EU countries will have to deal with hefty price tags.
While the "Moonshot" aims at the future, a "groundshot" initiative could address the issues facing cancer patients right now by making better use of services that are already available.
Treatment with targeted therapies Tafinlar + Mekinist resulted in 47% ORR versus chemotherapy (11%) and reduced risk of progression or death by 69%, showing...